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Abstract The glycation reaction by fructose, as well as that by
glucose, in control and diabetic rat lens was analyzed by using
antibodies which specifically recognize adducts of lysine with
fructose and with glucose. Levels of fructose adducts in diabetic
rat lens were 2.5 times that of the control, and correlated with
sorbitol levels. This was mainly due to enhanced glycation of L-
and Q-crystallins by fructose under diabetic conditions. These
data suggest that glycation by fructose may also play a role in
cataract formation under conditions of diabetes and aging.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The cross-linking of long-lived proteins, such as collagen
and lens crystallins, correlates with aging and diabetic proc-
esses [1]. Glycation, which proceeds during normal aging, and
at accelerated rates in diabetes, is involved in structural and
functional alterations of proteins and other cellular compo-
nents. The ¢nal products of the glycation reaction, referred to
as advanced glycation end products (AGE), are £uorescent
compounds, which increase under diabetic conditions as well
as the aging process, and, hence, have been suggested to be a
cause of these conditions [2].
Glucose is a major reducing substance in blood and is gen-
erally thought to be a major glycating agent in the body. Since
the level of fructose is about 100-fold lower than that of
glucose in most tissues, the involvement of fructose in the
glycation reaction (fructation) is generally thought to be
much less signi¢cant than glucose-induced glycation (gluca-
tion). In some tissues such as lens, kidney, and peripheral
nerve, however, a polyol metabolizing pathway, which con-
verts glucose to sorbitol via aldose reductase (AR) and then
sorbitol to fructose by sorbitol dehydrogenase (SDH), is ac-
tive [3]. Therefore fructose-induced glycation may also play a
role in such tissues.
It is well known that lens is one of the most susceptible
tissues to the glycation reaction because the half life of lens
proteins is very long and sugars also accumulate there at
relatively high levels. The glycation of lens crystallins is
thought to accelerate the aggregation of these proteins and
to cause cataract formation via decreasing the transparency
of the lens [4]. The concentration of fructose in the lens be-
comes equivalent to glucose concentration in severe cases of
diabetes [5,6]. In addition, fructose is known to be a more
potent glycating agent than glucose because the population
of its acyclic (open chain) form, which is the reactive species,
is approximately 10 times that of glucose [7]. However, studies
dealing with the fructation of proteins in vivo are few in
number [8] because there is no reliable and simple method
to quantitate the fructated proteins.
We have recently established an antibody which speci¢cally
recognizes fructated proteins with no need for any preliminary
treatment [9]. The use of this antibody, together with anti-
hexitol lysine antibody which speci¢cally recognizes the re-
duced form of an Amadori product formed in glucated pro-
teins [10], enables the analysis of the early events in the gly-
cation reaction by glucose and fructose to be carried out.
This paper describes the characterization of the early prod-
ucts in the glycation reaction of lens proteins in normal and
diabetic rats, along with a comparison of the contributions to
the glycation mode by glucose and fructose as this relates to
cataract formation.
2. Materials and methods
2.1. Materials
Glucose and fructose were purchased from Nakarai Tesque (Kyoto,
Japan). Sodium borohydride (NaBH4) was obtained from Wako Pure
Chemicals (Osaka, Japan). Horseradish peroxidase-conjugated goat
anti-rabbit IgG was purchased from ZYMED Laboratories (San
Francisco, CA, USA). Sephacryl S-300 was obtained from Pharmacia
LKB Biotechnology (Tokyo, Japan). Polyvinylidene di£uoride
(PVDF) transfer membrane (Immobilon) was a product of Millipore
(Bedford, MA, USA). Sodium cyanoborohydride (NaBH3CN), O-
phenylene-diamine dihydrochloride, TPCK-treated trypsin and ASP-
N were purchased from Sigma (St. Louis, MO, USA).
2.2. Preparation of lens homogenates from normal and streptozotocin
(STZ)-induced diabetic rats
Diabetic rats developed by injection of STZ (50 mg/kg) via the
intravenous route were kindly provided by Ono Pharmaceutical (Osa-
ka, Japan). These animals were sacri¢ced at 8, 20, 24, and 28 weeks
after STZ injection by decapitation under anesthesia with diethyl
ether. Normal and STZ-induced diabetic rat lenses were homogenized
in 1 ml of 50 mM phosphate-bu¡ered saline (PBS), pH 7.4. The
homogenates were ultracentrifuged at 100 000Ug at 4‡C for 30 min.
The supernatant was obtained and the protein concentration therein
was determined using a protein assay kit (Bio-Rad, Yokohama, Ja-
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pan). Immunoplate Maxisorp was purchased from Nunc (Rochester,
NY, USA).
2.3. Quanti¢cation of glucated and fructated lens proteins by enzyme
linked immunosorbent assay (ELISA)
Fifty microliter aliquots of samples containing 5 Wg protein were
added to a 96-well immunoplate and incubated for 2 h at room tem-
perature. For the quanti¢cation of glucation, samples were reduced by
adding 10 Wl of 0.1 M NaBH4 solution as described previously [10].
The plate was washed four times with PBS containing 0.05% Tween-
20 to remove unbound proteins and blocked with 1% bovine serum
albumin (BSA) in PBS by incubation at room temperature for 1 h.
The a⁄nity puri¢ed polyclonal antibody raised against 1-hexitol lysine
[10] diluted to 1:500 or that against fructated lysine [9] diluted to
1:250 with PBS was added and reacted at room temperature for 2 h.
After washing four times, horseradish peroxidase-conjugated goat
anti-rabbit IgG (1:2000 dilution in PBS) was added and allowed to
react for 2 h. Peroxidase activity was detected by adding 50 Wl of an
O-phenylenediamine dihydrochloride solution containing hydrogen
peroxide. The reaction was stopped by the addition of 50 Wl of 1 N
H2SO4 to each well. The absorbance at 490 nm was determined with
an immunoreader NJ200 (Intermed, Conshohocken, PA, USA) and
amounts of glucated and fructated proteins were expressed arbitrary
using glucated and fructated BSA as standards, respectively. The level
of fructation and glucation for each of the crystallin species (K, L and
Q) was quantitated in this manner.
2.4. Gel ¢ltration of control and STZ rat lens
Samples containing ten control rat lenses and ten 20-week diabetic
rat lenses were homogenized separately in 10 ml of bu¡er containing
0.05 M Tris, 0.5 M NaCl, 0.001 M EDTA, and 0.02% NaN3, pH 7.4,
at 4‡C. The soluble portion was centrifuged at 100 000Ug for 30 min.
After concentration by membrane ¢ltration, the supernatants were
fractionated into the KHM-, K-, LH-, LL- and Q-crystallin by gel
¢ltration (2.5U90 cm, Sephacryl S-300) using the same bu¡er at a
£ow rate of 9 ml/h at 4‡C. The electrophoretic pro¢les of these pro-
teins were nearly the same for each chromatography.
2.5. Detection of glucated proteins and fructated proteins by
immunoblotting
For the detection of fructated proteins by immunoblotting, we bio-
tinylated anti-fructated lysine IgG using a protein biotinylation system
(Amersham, Uppsala, Sweden), since the goat anti-rabbit IgG
(the second antibody) bound non-speci¢cally to rat Q-crystallins,
although it did not cross-react with Q-crystallins in a native confor-
mation [10]. Whole lens proteins were subjected to 15% SDS-PAGE
and were transferred onto PVDF membranes under semi-dry condi-
tions using a Trans-blot (Bio-Rad, Hercules, CA, USA). For Immu-
noblot analysis, by anti-hexitol Lys IgG, the blot was reduced with
0.1 M NaBH4 for 2 h at room temperature prior to incubation
with the IgG [10,11]. The membranes were blocked by incubation
with 4% skimmed milk in Tris-bu¡ered saline (TBS; 10 mM Tris-
HCl, pH 7.4, and 0.15 M NaCl) at room temperature for 1 h with
gentle agitation, washed four times with TBS containing 0.05% Tween
20 for 15 min each time, and then incubated with the diluted (1:500)
biotinylated anti-fructated lysine IgG at 4‡C overnight. After washing,
the samples were incubated with the horseradish peroxidase-conju-
gated streptavidin diluted to 1:2000 for 30 min at room temperature
and then washed for 6 h. The chemiluminescence method was em-
ployed to amplify the signal using an ECL kit (Amersham, Uppsala,
Sweden).
2.6. Isolation of tryptic peptide from fructated Q-crystallins by reverse
phase-high performance liquid chromatography (RP-HPLC)
After 6 days incubation with 100 mM fructose and 100 mM
NaBH3CN, approximately 100 Wg of the Q-crystallins were dissolved
in 500 Wl of 50 mM Tris-HCl, pH 7.4, and digested with TPCK-
treated trypsin at a protein to enzyme ratio of 50:1 for 24 h at
37‡C. The fructated peptides were separated by RP-HPLC (LC6A,
Shimadzu, Kyoto, Japan) on a Cosmosil C18 column (4.6U250 mm,
Nacalai Tesque, Kyoto, Japan), at a £ow rate of 0.8 ml/min, with a
gradient of 5^80% B over 60 min. Solvent A (0.05% TFA in H2O);
solvent B (0.05% TFA in acetonitrile). Peptides were detected by
measuring absorbance at 280 nm. Each peak was collected, lyophi-
lized and then subjected to further analysis.
2.7. Mass spectrometrical analysis of fructated peptide
Tryptic peptides, puri¢ed from the RP-HPLC, were dissolved in 1 Wl
of 50% acetonitrile, 0.05% TFA, mixed with 1 Wl of saturated
K-cyanohydroxycinnamic acid (K-CHCA; Aldrich, Milwaukee, WI,
USA) dissolved in 5% acetonitrile, 0.05% TFA, and applied to a
sample plate. Matrix-assisted laser desorption/ionization time-of-£ight
mass spectrometry (MALDI-TOF-MS) was performed on a Voyager-
RP equipped with a delayed-extraction system (Perceptive Biosystems,
Flamingham, MA, USA) with an N2 gas discharge laser (337 nm).
2.8. Amino acid sequencing and amino acid analysis
The isolated tryptic peptide was subjected to amino acid sequencing
in a gas-phase protein sequencer (ABI-477A, Applied Biosystems,
Drive Foster, CA, USA). PTH-amino acids were quantitated by
RP-HPLC (Applied Biosystems). The peptide was also hydrolyzed
in 6 N HCl at 100‡C for 24 h under vacuum. Amino acid analysis
was carried out with an automatic amino acid analyzer (L-8500, Hi-
tachi, Tokyo, Japan).
2.9. Measuring sorbitol content in rat lenses
The sorbitol content of rat lens was determined using a method
described previously [13], by measuring the enzymatic formation of
NADH from NAD with sorbitol dehydrogenase.
3. Results
Fig. 1a shows quantitative data for the levels of glucated
proteins in normal and diabetic rat lens, as assayed by ELISA
using an anti-hexitol lysine antibody, which speci¢cally recog-
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Fig. 1. ELISA analysis of levels of fructated or glucated lens pro-
teins in control and diabetic rats. Each lens was prepared individu-
ally from four controls and four diabetic rats at 8, 20, 24 and 28
weeks after STZ injection and homogenized. After ultracentrifuga-
tion, 5 Wg of soluble proteins were subjected to ELISA using the
anti-hexitol lysine antibody (a) or the anti-fructated lysine antibody
(b). CTR: control; DM: diabetes.
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nizes the glucated proteins after reduction with sodium bor-
ohydride. The levels of glucated proteins increased and
reached a plateau at 20 weeks, when cataract formation was
obvious and severe.
The fructation reaction, however, started to advance at 8
weeks, reaching a maximum level at 24 weeks, and then de-
creased considerably at 28 weeks (Fig. 1b). Since only soluble
proteins after ultracentrifugation were used for the ELISA
assay, this suggests that fructated proteins became insoluble
at an advanced stage of diabetes. As described below, the
solubility may be decreased, as the result of the accelerated
formation of cross-linked insoluble AGEs in fructated pro-
teins vs. glucated proteins.
Since fructose is mainly produced by the polyol metaboliz-
ing pathway and sorbitol is a direct precursor of fructose,
sorbitol contents in lens were measured and compared with
levels of fructated proteins in rat lenses sacri¢ced 4 weeks
after STZ injection (Fig. 2). The levels of sorbitol were sig-
ni¢cantly higher in diabetic rats (16.08 þ 7.70 Wmol/g), com-
pared to those in control rats (0.27 þ 0.12 Wmol/g) (P6 0.01).
The levels of fructated proteins were correlatively higher in
diabetic rats (11.47 þ 1.46) than those in control rats
(5.01 þ 1.20) (P6 0.01) and correlated to the levels of sorbitol.
These data clearly demonstrate that fructose, produced
through the polyol metabolizing pathway is actually involved
in the fructation of lens proteins.
To characterize the fructation and glucation reaction com-
paratively at advanced stages of glycation, total lens proteins
were incubated either with 100 mM glucose or with 100 mM
fructose for 7 days at 37‡C, and the £uorescent materials
corresponding to AGE were then quantitated by £uorescence
spectrophotometry (data not shown). While the levels of £uo-
rescence in the glucated proteins increased only about 30%
compared with the control, a signi¢cant elevation, about 10
times that of the control, was observed in fructated proteins.
These data, which are consistent with our previous report [9],
clearly show that the glycation by fructose proceeds at an
accelerated rate compared with the same concentration of
glucose.
Rat lens crystallins are composed of three major classes, K,
L, and Q. To characterize their susceptibility to glycation by
glucose and fructose independently, immunoblot analysis
(Fig. 3) and quantitation by ELISA (Fig. 4) were carried
out using both the anti-hexitol lysine antibody and the anti-
fructated lysine antibody. Levels of glucation and fructation
of Q-crystallins were originally high even in normal lens, and
were further increased in diabetic lens. The level of glycation
of L-crystallins was lower than the Q-crystallins in normal lens,
but increased markedly in diabetic rats in terms of both glu-
cation and fructation. Thus, the major contribution to glyca-
tion occurred in the L-crystallins, suggesting that L-crystallins
may play an important role in the formation of cataract as the
result of diabetic complications.
Q-Crystallins, in which the glycated fraction was removed by
passing through a boronate column, was incubated with 100
mM fructose and NaBH3CN for 6 days. After TPCK-tryptic
digestion, the resulting peptides were separated on RP-HPLC
(data not shown), and each fraction was subjected to mass
spectrometric analysis. We detected two candidate peptides
which could have been modi¢ed by one or two moles of
fructose. Since these fractions contained some impurity, they
were re-chromatographied on RP-HPLC after digestion with
ASP-N, to give one pure peptide, although the other one
could not be recovered due to its low content in the fraction.
The molecular mass of the peptide (1021.1, Fig. 5) suggested
that the pure protonated peptide corresponded to the proto-
nated N-terminal peptide (Gly-1 to Glu-7, the calculated
mass: 857) with an excess of 164. The minor peptide likely
contained two moles of bound fructose at the K-amino group
of Gly-1 and the O-amino group of Lys-2. Amino acid analysis
identi¢ed 6 amino acids which exactly matched the residues
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Fig. 3. Immunoblot analysis of glucated and fructated lens proteins
in control and diabetic rats. Five Wg of the crystallins isolated at 20
weeks after STZ injection were subjected to immunoblot analysis us-
ing the anti-hexitol lysine antibody (b) and anti-fructated lysine
antibody (c). W: whole lens proteins; C.B.B.: Coomassie brilliant
blue; Std: standard marker.
Fig. 2. Correlation between sorbitol content and fructation in rat
lenses. The sorbitol content and levels of fructated proteins in rat
lenses were compared in control and diabetic groups. CTR: control;
DM: diabetes.
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Lys-2 to Glu-7 in Q-crystallins at molar ratios from 0.7 to 1.2
and a trace amount of glycine, the N-terminal amino acid
residue (data not shown). These collective data suggest that
fructation mainly occurred at the K-amino group of the N-
terminal Gly.
4. Discussion
Aldose reductase, a rate-determining enzyme of the polyol
metabolizing pathway, is a target of a drug designed to ameli-
orate diabetic complications [12]. It has been demonstrated
that such drugs are actually e¡ective in suppressing cataract
formation in lens [13]. A generally accepted mechanism by
which the drug exerts its e¡ect is through suppression of the
formation of sorbitol, a sugar alcohol which penetrates the
cell membrane with di⁄culty and, therefore, contributes to
the elevation of osmolarity within cells. Rat lens, however,
expressed fairly large amounts of AR but quite low levels of
SDH compared with other tissues, and hence this accumula-
tion of sorbitol in lens would be caused by low SDH activity.
A recent study demonstrated that an inhibitor of SDH also
was capable of improving the diabetic complications by an
unknown mechanism [14]. Since SDH converts sorbitol to
fructose, a more potent glycating sugar than glucose, the gly-
cation of proteins by fructose may be signi¢cant in tissues
with high polyol metabolizing activity.
Lens represents one of the tissues in which fructose accu-
mulates at a level approximately equivalent to glucose under
diabetic conditions and the half-life of its major structural
proteins, crystallins, is quite long [6]. Thus glycation by the
accumulated fructose would also cause defects in crystallin
function and consequently a serious damage to lens function
[15]. However, since there was no adequate method to distin-
guish glucation from fructation, no reliable data to assess the
roles of glucation and fructation in cataract formation in vivo
has been presented. Quite recently we developed a speci¢c
antibody against fructated proteins [9]. This, together with
our anti-hexitol lysine antibody [10], enabled us to analyze
precisely and independently the role of glucation and fructa-
tion in vivo.
Glycation occurred in signi¢cant levels even in control rat
lens. The Amadori product accumulated at very high levels in
diabetic rat lens 8 weeks after STZ injection. Compared to
Amadori products, the early products reacted with fructose,
also referred to as a Heyns product, and did not accumulate
to as great an extent, although AGE formation as judged by
measuring £uorescent materials was much higher than gluca-
tion. This would be due to the acceleration of AGE formation
from the Heyns product vs. the Amadori product, the result
of which is to keep Heyns products at lower levels. Our data
showed that the fructation of lens proteins correlates to the
sorbitol content, as evidenced by the control group vs. the
diabetic rat lenses. These data support our hypothesis that
the fructation of lens proteins increases under conditions in
which the polyol metabolizing pathway is active.
When the glycation reaction was analyzed by immunoblot-
ting at the levels of the molecular species of crystallins, the
glycation of Q-crystallins was higher than other forms. How-
ever, in a diabetic lens, the L-crystallins rather than Q-crystal-
lins were found to be more susceptible to glycation by both
glucose and fructose as judged by the ELISA assay. This
di¡erence may re£ect the tertiary structures of crystallin iso-
forms. While antibodies react with antigenic proteins in non-
denaturing conditions by ELISA, only denatured forms are
detected by immunoblotting. In fact, goat anti-rabbit IgG
reacted highly with Q-crystallins in immunoblots, but barely
reacted in the ELISA assay. Although several reports con-
cerning glycation of K-crystallin in relation to its chaperone
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Fig. 5. Analysis of fructated peptides in Q-crystallins by MALDI-
TOF-MS. After incubation of 100 Wg of Q-crystallins with 100 mM
fructose, tryptic peptides were separated by RP-HPLC and then re-
chromatographed on RP-HPLC after digestion with ASP-N. The re-
sultant peptide was analyzed with MALDI-TOF-MS. The obtained
mass values (1021.1) correspond to the mass of the protonated
(MH), amino-terminal peptides Gly-1 to Glu-7 with an excess of
164.
Fig. 4. ELISA analysis of the levels of fructation and glucation in
crystallins isolated from control and diabetic rat lenses. After gel ¢l-
tration, each fraction (K, L, Q) was collected and subjected to ELISA
using the anti-hexitol lysine antibody (a) or the anti-fructated lysine
antibody (b). CTR: control; DM: diabetes.
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activity have appeared [15], susceptibility to the glycation re-
action was much less than the other two isoforms. Thus, the
L- and Q-crystallins might be more important in cataract for-
mation in terms of diabetic complications. Since the tertiary
structure of K-crystallin has not yet been determined, the
mechanism by which the di¡erent crystallin isoforms react
remains unclear.
The fructation detected by this antibody would be expected
to occur at the O-amino group of lysine residues because fruc-
tated lysine was the antigen [9]. Our data showed that L- and
Q-crystallins were susceptible to glycation by fructose, and
Zhao et al. [16] showed the sites of glycation in L-crystallin
by fructose. Although Pennington et al. [17] and Smith et al.
[18] reported the sites of glycation in Q-crystallin by fructose,
we further investigated the Q-crystallin situation.
It is not possible to distinguish fructose-derived from glu-
cose-derived AGEs at this time because they probably share a
common structure with respect to £uorescence, and no speci¢c
method to distinguish them has yet been developed. Therefore
it is of importance to evaluate the contribution of glucation
and fructation in the glycation reaction at an early stage. We
herein demonstrated for the ¢rst time that the fructation of
crystallins may also contribute to cataract formation by meas-
uring the early products of the fructation reaction with anti-
fructated lysine antibody. It is known that mice hardly devel-
op cataract in the eyes, and that the enzymes involved in the
polyol metabolizing pathway are much lower than they are in
rats. However, transgenic mice overproducing AR develop
cataract and accumulate sorbitol in the lens like the rat [19].
This approach is also applicable to other tissues such as pe-
ripheral nerves and kidney and will be useful in evaluating the
involvement of the polyol metabolizing pathway in diabetes
mellitus and aging.
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